Pilar Avinash, Gupta Meetakshi, Ghosh Laskar Sarbani, Laskar Siddhartha
Department of Radiation Oncology, Tata Memorial Hospital, Dr Ernest Borges' Marg, Parel, Mumbai, MS, India 400012.
Ecancermedicalscience. 2017 Jun 29;11:750. doi: 10.3332/ecancer.2017.750. eCollection 2017.
Intraoperative radiotherapy (IORT) is a technique that involves precise delivery of a large dose of ionising radiation to the tumour or tumour bed during surgery. Direct visualisation of the tumour bed and ability to space out the normal tissues from the tumour bed allows maximisation of the dose to the tumour while minimising the dose to normal tissues. This results in an improved therapeutic ratio with IORT. Although it was introduced in the 1960s, it has seen a resurgence of popularity with the introduction of self-shielding mobile linear accelerators and low-kV IORT devices, which by eliminating the logistical issues of transport of the patient during surgery for radiotherapy or building a shielded operating room, has enabled its wider use in the community. Electrons, low-kV X-rays and HDR brachytherapy are all different methods of IORT in current clinical use. Each method has its own unique set of advantages and disadvantages, its own set of indications where one may be better suited than the other, and each requires a specific kind of expertise. IORT has demonstrated its efficacy in a wide variety of intra-abdominal tumours, recurrent colorectal cancers, recurrent gynaecological cancers, and soft-tissue tumours. Recently, it has emerged as an attractive treatment option for selected, early-stage breast cancer, owing to the ability to complete the entire course of radiotherapy during surgery. IORT has been used in a multitude of roles across these sites, for dose escalation (retroperitoneal sarcoma), EBRT dose de-escalation (paediatric tumours), as sole radiation modality (early breast cancers) and as a re-irradiation modality (recurrent rectal and gynaecological cancers). This article aims to provide a review of the rationale, techniques, and outcomes for IORT across different sites relevant to current clinical practice.
术中放疗(IORT)是一种在手术过程中将大剂量电离辐射精确地传递至肿瘤或肿瘤床的技术。肿瘤床的直接可视化以及将正常组织与肿瘤床隔开的能力,使得在将肿瘤剂量最大化的同时,将正常组织的剂量最小化。这使得IORT的治疗比得到改善。尽管它在20世纪60年代就已被引入,但随着自屏蔽移动直线加速器和低千伏IORT设备的出现,它再度受到欢迎。这些设备通过消除手术期间患者转运至放疗处的后勤问题或建造屏蔽手术室,使得其在社区中得到更广泛的应用。电子、低千伏X射线和高剂量率近距离放疗都是目前临床使用的IORT的不同方法。每种方法都有其独特的优缺点、各自的一组适应证(其中一种可能比另一种更适合),并且每种方法都需要特定类型的专业知识。IORT已在多种腹部肿瘤、复发性结直肠癌、复发性妇科癌症和软组织肿瘤中证明了其疗效。最近,由于能够在手术期间完成整个放疗疗程,它已成为选定的早期乳腺癌的一种有吸引力的治疗选择。IORT已在这些部位以多种角色使用,用于剂量递增(腹膜后肉瘤)、外照射放疗剂量递减(儿科肿瘤)、作为唯一的放疗方式(早期乳腺癌)以及作为再照射方式(复发性直肠癌和妇科癌症)。本文旨在综述与当前临床实践相关的不同部位IORT的原理、技术和结果。